Novel hemostatic gel and powder as rescue agents for arterial bleeding related to lumen-apposing metal stent placement
Endoscopy · 01.12.2025 · 57 (S 01 S 01) · E58-E59
DOI: 10.1055/a-2512-4496 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.12.2025. Verfasst von Butros Fakhoury und 6 weiteren Autor:innen. Beteiligte Einrichtung: Virginia Commonwealth University Medical Center, Richmond, United States. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Intraprocedural bleeding following endoscopic ultrasound (EUS)-guided placement of lumen-apposing metal stents (LAMSs) is not an infrequent complication. Significant arterial bleeding may require interventions such as coil embolization or surgical intervention [ 1 ]. Identifying and accessing the bleeding site can be particularly challenging when it is obscured by the stent. Recent advances in topical hemostatic agents, such as gels and powders, offer the benefits of broad targeted therapy [ 2 ]. We report a unique case detailing the successful management of active arterial bleeding from the gastroepiploic artery after balloon dilation of a LAMS using topical hemostatic gel and powder ([ Video 1 ]). Quality: mobile 360 480 720 Download Endoscopic ultrasound-guided placement of lumen-apposing metal stent in a 39-year-old man with recurrent walled-off pancreatic necrosis, complicated by arterial bleeding, successfully managed with a combination of hemostatic gel and powder.Video 1 A 39-year-old man with a history of necrotizing pancreatitis and walled-off pancreatic necrotic collections presented with abdominal pain and recurrent walled-off pancreatic necrosis. A computed tomography (CT) angiogram revealed no evidence of a pseudoaneurysm. Under EUS guidance, the stomach wall and the cyst were punctured using an electrocautery-equipped LAMS stent (AXIOS; Boston Scientific, Marlborough, Massachusetts, USA) ([ Fig. 1 ]). A significant arterial bleed occurred from beneath the stent during dilation ([ Fig. 2 ]). Hemostasis was achieved using topical hemostatic gel (PuraStat; 3-D Matrix Europe SAS, Caluire-et-Cuire, France) and powder (EndoClot Plus, Inc., Santa Clara, California, USA) ([ Fig. 3 ], [ Fig. 4 ], [ Fig. 5 ]). The post-procedure CT angiogram showed no active bleeding, and the culprit was identified as the gastroepiploic artery. The patient remained stable and was discharged without requiring additional intervention. Fig. 1 Successful deployment of the lumen-apposing metal stent (LAMS). Fig. 2 Brisk arterial bleeding beneath the LAMS stent post-dilation. Fig. 3 Administration of hemostatic gel at the suspected bleeding site using a specialized catheter. Fig. 4 Mild residual oozing identified after the application of hemostatic gel. Fig. 5 Endoscopic confirmation of hemostasis following the application of topical hemostatic agents. Topical hemostatic agents achieve hemostasis by forming mechanical barriers that enhance clot formation [ 3 ]. Hemostatic gel, in particular, maintains visibility and has a lower rebleeding rate [ 4 ]. While these agents are approved by the U.S. Food and Drug Administration for venous bleeding, their efficacy in managing arterial bleeding remains uncertain [ 5 ]. This case demonstrates the evolving role of topical hemostatic agents in managing complex bleeding situations where traditional methods are impractical. Further studies are warranted to refine management strategies and evaluate the long-term outcomes. Endoscopy_UCTN_Code_CPL_1AL_2AD Endoscopy E-Videos https://eref.thieme.de/e-videos E-Videos is an open access online section of the journal Endoscopy , reporting on interesting cases and new techniques in gastroenterological endoscopy. All papers include a high-quality video and are published with a Creative Commons CC-BY license. Endoscopy E-Videos qualify for HINARI discounts and waivers and eligibility is automatically checked during the submission process. We grant 100% waivers to articles whose corresponding authors are based in Group A countries and 50% waivers to those who are based in Group B countries as classified by Research4Life (see: https://www.research4life.org/access/eligibility/ ). This section has its own submission website at https://mc.manuscriptcentral.com/e-videos . Publication History Article published online: 23 January 2025 © 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Autor:innen und Institutionen
- Virginia Commonwealth University Medical Center, Richmond, United States.
- Beth Israel Deaconess Medical Center, Boston, United States.
- Tufts Medical Center, Boston, United States.
- Tufts University School of Medicine, Boston, United States.
ORCID-Profile: Erika Tsuchiyose
Zitieren
APA
Fakhoury, B., Awadalla, M., Talanian, M., Zeina, T., Tsuchiyose, E., Natov, N., & Holzwanger, E. (2025). Novel hemostatic gel and powder as rescue agents for arterial bleeding related to lumen-apposing metal stent placement. Endoscopy, 57(S 01 S 01), E58-E59. https://doi.org/10.1055/a-2512-4496
Vancouver
Fakhoury B, Awadalla M, Talanian M, Zeina T, Tsuchiyose E, Natov N, et al. Novel hemostatic gel and powder as rescue agents for arterial bleeding related to lumen-apposing metal stent placement. Endoscopy. 2025;57(S 01 S 01):E58-E59. doi:10.1055/a-2512-4496
BibTeX
@article{Fakhoury2025,
author = {Fakhoury, Butros and Awadalla, Mohanad and Talanian, Michael and Zeina, Tanya and Tsuchiyose, Erika and Natov, Nikola and Holzwanger, Erik},
title = {Novel hemostatic gel and powder as rescue agents for arterial bleeding related to lumen-apposing metal stent placement},
journal = {Endoscopy},
year = {2025},
volume = {57},
number = {S 01 S 01},
pages = {E58--E59},
doi = {10.1055/a-2512-4496}
}
EUVIMED